Red List

TRVITrevi Therapeutics, Inc.

Healthcare · Biotechnology · small-cap ($1.4B)
-21.3%
from rolling 252-day high of $20.22 set 2026-07-17 · 55d ago
Current
$15.91
Decline depth
-21.3%
Decline σ
8.1σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$TRVI landed on the list 2026-03-14, down 22.4% from its 52-week high that day — now down -21.3%.

It has clawed back 32.9 percentage points off that level. It bottomed 26.3% below that high along the way.

From the 52-week high as of 2026-03-16 to today. Split-adjusted. Observed, not a forecast.

Structural break signals

TRVI qualifies for the Red List on decline depth.

Decline depth
-21.3%
From rolling 252-day high of $20.22, 55d ago. Past the 20% Watch threshold.
Time-frame continuity
2/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
8.1σ
Drop over the last 20 bars in units of daily volatility (2.29%/day). Past the ≥8σ Red List threshold — an extreme move.

The structural read

What price action says about TRVI.

TRVI qualifies for the Red List on decline depth — down -21.3% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown.

Cross-confirmation: decline sigma also reads 8.1σ over 20 bars.

Earnings on file: 2026-03-17. Earnings dates don't affect tiering.

Questions about TRVI

What people ask.

Why is TRVI on Broken Stocks?

TRVI qualifies for the Red List on decline depth. It is down -21.3% from its rolling 252-day high of $20.22, set on 2026-07-17 — 55d ago.

Is TRVI a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. TRVI is down -21.3% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is TRVI a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is TRVI trading inside its 52-week range?

At $15.91, TRVI sits 100.0% of the way from its 52-week low ($4.85) to its 52-week high ($14.39). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has TRVI been declining?

The current 21.3% decline accrued over 55d, which annualizes to roughly -141.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does TRVI compare to its sector?

There are 283 other Healthcare tickers on Broken Stocks: 155 Red, 79 Amber, 49 Watch, with 28 showing recovering structural signals. Median sector decline is -36.0% — TRVI's decline is shallower than the sector median.

Does TRVI's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-03-17) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.